MTHFR C677T polymorphism and osteoporotic fractures

Hormone and Metabolic Research

Volumn 39, Issue 8, 2007, Pages 543-547

  Valero, C ^a   Alonso, M A ^a   Zarrabeitia, M T ^a   Viadero, C ^b   Hernandez J L ^a   Riancho, J A ^a,c  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b Centro de Mayores Cueto   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Homocysteine; Meta analysis; Methylenetetrahydrofolate reductase; Osteoporosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FRAGILITY FRACTURE; GENE LOCATION; GENOTYPE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VERTEBRA FRACTURE;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FRACTURES, BONE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIP FRACTURES; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SPINAL INJURIES;

EID: 34548367544     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985131     Document Type: Article

References (29)

1. Hamerman D. Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. QJM 2005; 98: 467-484
2. Jorgensen L, Joakimsen O, Rosvold Berntsen GK, Heuch I, Jacobsen BK. Low bone mineral density is related to echogenic carotid artery plaques: a population-based study. Am J Epidemiol 2004; 160: 549-556
3. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002; 325: 1202-1207
4. MacLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE et al. Homocysteine as a predictive factor for hip fractures in older persons. N Engl J Med 2004; 350: 2042-2049
5. Meurs JBJ Van, Dhonukshe-Rutten RAM, Pluijm SMF, Klift M Van der, Jonge R de, Lindemans J et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004; 350: 2033-2041
6. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 2005; 365: 224-232
7. Miyao M, Morita H, Hosoi T, Kurihara H, Inoue S, Hoshimo S et al. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 2000; 66: 190-194
8. Villadsen MM, Bünger MH, Carstens M, Stenkjaer L, Langdahl BL. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD. Osteoporos Int 2005; 16: 411-416
9. Maclean RR, Karasik D, Selhub J, Tucker KL, Ordovas J, Russo GT et al. Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J Bone Miner Res 2004; 19: 410-418
10. MacDonald HM, MacGuigan FE, Fraser WD, New SA, Ralston SH, Reid DM. Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Bone 2004; 35: 957-964
11. Abrahamsen B, Jorgensen HL, Nielsen TL, Andersen M, Haug E, Schwarz P et al. MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men-results from the Odense Androgen Study. Bone 2006; 38: 215-219
12. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR et al. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause:longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res 2003; 18: 723-729
13. Bathum L, Bomemann-Hjelmorbg J von, Christiansen L, Madsen JS, Skytthe A, Christensen K. Evidence for an association of methylene tetrahydrofolate reductase polymorphism C677T and an increased rsik of fractures: results from a population-based Danish study. Osteoporos Int 2004; 15: 659-664
14. Jorgensen HL, Madsen JS, Madsen B, Saleh MMA, Abrahamsen B, Fenger M et al. Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in Danish postmenopausal women. Calcif Tissue Int 2002; 71: 386-392
15. Li M, Lau EM, Woo J. Methylenetetrahydrofolate reductase polymorphism (MTHFR C677T) and bone mineral density in Chinese men and women. Bone 2004; 35: 1369-1374
16. Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 1997; 349: 1591-1593
17. Ralston SH. Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 2002; 87: 2460-2466
18. Michaelsson K, Melhus H, Ferm H, Ahlbom A, Pedersen NL. Genetic liability to fractures in the elderly. Arch Intern Med 2005; 165: 1825-1830
19. Cagnacci A, Baldassari F, Rivotta G, Arangino S, Volpe A. Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone 2003; 33: 956-959
20. Dhonukshe-Rutten RAM, Pluijm SMF, Groot LCPM de, Lips P, Smit JH, Staveren WA van. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 2005; 20: 921-929
21. Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Drevon CA, Gjessing HK et al. Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 2006; 166: 88-94
22. Raisz LG. Homocysteine and osteoporotic fractures-culprit or bystander? N Engl J Med 2004; 350: 2089-2090
23. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR et al. Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone 2005; 36:577-583
24. Powers HJ. Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J Nutr 2005; 135 (12 Suppl): 2960S-2966S
25. Ulrich CM. Nutrigenetics in cancer research - folate metabolism and colorectal cancer. J Nutr 2005; 135: 2698-2702
26. Balk EM, Raman G, Tatsioni A, Chung M, Lau J, Rosenberg IH. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med 2007; 167: 21-30
27. Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006; 296: 2720-2726
28. Green TJ, MacMahon JA, Skeaff CM, Williams SM, Whiting SJ. Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial. Am J Clin Nutr 2007; 85: 460-464
29. Hong X, Hsu YH, Terwedow H, Tang G, Liu X, Jiang S et al. Association of the methylenetetrahydrofolate reductase C677T polymorphism and fracture risk in Chinese postmenopausal women. Bone 2007; 40: 737-742